RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of FGEN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for FibroGen stock price on Wednesday moving between $2.30 and $2.68
(Updated on Mar 27, 2024)

Buy or Hold candidate since Mar 12, 2024 Gain 36.51% PDF

The FibroGen stock price gained 5.74% on the last trading day (Wednesday, 27th Mar 2024), rising from $2.44 to $2.58. During the last trading day the stock fluctuated 16.52% from a day low at $2.30 to a day high of $2.68. The price has risen in 8 of the last 10 days and is up by 29% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 316 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $4.76 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 91.70% during the next 3 months and, with a 90% probability hold a price between $3.94 and $6.99 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

FGEN Signals & Forecast

The FibroGen stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $2.48 and $2.12. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Friday, February 09, 2024, and so far it has fallen -5.49%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for FibroGen stock

On the downside, the stock finds support just below today's level from accumulated volume at $2.38 and $2.37. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, FibroGen finds support just below today's level at $2.38. If this is broken, then the next support from accumulated volume will be at $2.37 and $2.17.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.380 between high and low, or 16.52%. For the last week, the stock has had daily average volatility of 12.25%.

Our recommended stop-loss: $2.46 (-4.74%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 79 and this increases the risk substantially. There is a sell signal from a pivot top found 32 days ago.)

Trading Expectations (FGEN) For The Upcoming Trading Day Of Thursday 28th

For the upcoming trading day on Thursday, 28th we expect FibroGen to open at $2.52, and during the day (based on 14 day Average True Range), to move between $2.30 and $2.86, which gives a possible trading interval of +/-$0.283 (+/-10.96%) up or down from last closing price. If FibroGen takes out the full calculated possible swing range there will be an estimated 21.91% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $2.64 (2.33%) than the support at $2.38 (7.75%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is FibroGen stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for FibroGen stock to perform well in the short-term.

Current score: 4.053 Buy Candidate Unchanged

Predicted Opening Price for FibroGen of Thursday, March 28, 2024

Fair opening price March 28, 2024 Current price
$2.52 ( 2.33%) $2.58

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for FGEN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.90 12.40 %
R2 2.75 6.78 %
R1 2.67 3.30 %
Current price: 2.58
Support S1 2.37 -7.95 %
S2 2.29 -11.43 %
S3 2.14 -17.05 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.73 5.81 %
R2 2.72 5.43 %
R1 2.64 2.33 %
Current price 2.58
Support S1 2.38 -7.75%
S2 2.37 -8.14%
S3 2.17 -15.89%

FAQ

What is the symbol for FibroGen Stock and on which exchange is it traded?
The symbol for FibroGen is FGEN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell FibroGen Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for FibroGen stock to perform well in the short-term.

How to buy FibroGen Stock?
FibroGen Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy FibroGen Stock.

What's the current price of FibroGen Stock?
As of the end of day on the 2024-03-27, the price of an FibroGen (FGEN) share was $2.58.

What is the 52-week high and low for FibroGen Stock?
The 52-week high for FibroGen Stock is $20.90 and the 52-week low is $0.335.

What is the market capitalization of FibroGen Stock?
As of the 2024-03-27, the market capitalization of FibroGen is 241.002M.

When is the next earnings date for FibroGen?
The upcoming earnings date for FibroGen is May 13, 2024.
Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT